How to Inject Peptides Subcutaneously: Step-by-Step Guide [2026 Medical Standards]

Subcutaneous injection delivers peptides into the fatty tissue just under your skin, bypassing the digestive enzymes that destroy most peptides taken orally. The technique is straightforward — but the details matter. An error in angle, site preparation, or needle disposal can cause tissue damage, infection, or injury. This guide covers the complete procedure for anyone self-administering a prescription peptide under physician supervision, including every safety standard that applies to home use.

Key Takeaways

Subcutaneous injections target the fatty layer between your skin and muscle using a 31-gauge insulin syringe inserted at 45–90 degrees to a depth of about half an inch.
Rotating injection sites daily prevents lipohypertrophy — abnormal fatty lumps under the skin that block medication absorption.
Used needles must go into an FDA-cleared sharps container immediately after every injection, per OSHA’s Bloodborne Pathogens Standard (29 CFR 1910.1030). This applies to home self-administration.
Signs of anaphylaxis — difficulty breathing, facial swelling, hives — require calling 911, not waiting.
BPC-157, CJC-1295, and ipamorelin are FDA Category 2 substances and cannot be legally compounded under current regulations.

Before you start All injectable peptide protocols require a valid prescription and explicit guidance from your prescribing physician. Your physician and pharmacy provide the dose, protocol, and any instructions specific to your medication. Never substitute injectable routes or adjust dosing without direct physician approval.

Why Subcutaneous Injection Works

The target tissue determines everything about this technique.

Your skin has three layers. The outermost is the epidermis. Below that sits the dermis, which contains nerves and blood vessels. Below the dermis is the hypodermis — the fatty subcutaneous layer where this injection goes.

That fat layer is threaded with tiny blood capillaries. Peptides injected there absorb directly into your bloodstream — no first-pass liver metabolism, no stomach acid degrading the molecule. For peptides under 16 kilodaltons (kDa) in molecular weight, this route provides high bioavailability and rapid onset.

FDA-approved peptide medications — including liraglutide (Victoza, Saxenda) and semaglutide (Ozempic, Wegovy) — as well as compounded peptides from licensed 503A pharmacies, all use this route. The technique described here applies across those protocols.

Subcutaneous vs. intramuscular — they are not interchangeable

Feature	Subcutaneous (SubQ)	Intramuscular (IM)
Target tissue	Fat layer (hypodermis)	Muscle tissue
Needle depth	~½ inch	~1 inch
Needle gauge	29–31 gauge	22–25 gauge
Insertion angle	45–90 degrees	90 degrees
Typical use	Peptides, insulin	Vaccines, some hormones

Peptides are almost always subcutaneous. Delivering a medication to the wrong tissue layer changes how and how fast it absorbs. Never switch routes without your physician’s explicit instruction.

Learn more about how subcutaneous absorption works and which delivery routes apply to different peptide compounds.

What You Need

Gather everything before you start. Once you touch the needle, you’re committed to completing the injection.

Item	Specification	Where to get it
Insulin syringe with needle	31-gauge, 1 mL capacity, 5–8 mm needle length	Pharmacy (Rx or OTC depending on state)
Peptide medication	Prescribed dose from licensed 503A compounding pharmacy or FDA-approved manufacturer	Only through your pharmacy
Bacteriostatic water	For reconstituting lyophilized (powdered) peptides	Pharmacy
Alcohol pads	70% isopropyl alcohol, sterile	Pharmacy, grocery store
FDA-cleared sharps container	Puncture-resistant, tight lid, biohazard label	Pharmacy, online
Clean gauze or cotton balls	For post-injection site pressure	Pharmacy, grocery store

About needle gauge: The gauge number indicates thickness — higher means thinner. A 31-gauge needle is ultra-fine, which is why it causes minimal discomfort for subcutaneous injections. A 27-gauge needle flows faster but causes more discomfort. Use 29–31 gauge for subcutaneous peptide injections unless your provider specifies otherwise.

Some peptide medications come in prefilled syringes or insulin pen devices with dial-dose precision. Ask your pharmacy whether your medication is available in these formats.

Learn more about syringe formats and when prefilled options apply to your protocol.

How to Prepare Your Dose

For liquid peptides already in solution

Remove the vial from the refrigerator and let it warm to room temperature — about 5–10 minutes. Cold injections are more uncomfortable.

Wash your hands with soap and warm water for a full 20 seconds. Set up on a clean, flat surface. Wipe the rubber stopper on the vial with a fresh alcohol pad and let it dry completely before proceeding.

Draw air into the syringe equal to your prescribed dose volume.
Insert the needle into the vial through the rubber stopper.
Push the air in, then invert the vial.
Pull the plunger back to your prescribed dose marking.
Tap the barrel gently and push out any air bubbles until the dose marking is exact.
Verify the syringe shows your exact prescribed dose against your prescription label.

If you’re not certain you’ve drawn the correct dose, push everything back into the vial and redraw. Never inject a dose you’re unsure about.

For lyophilized (powdered) peptides — reconstitution steps

Lyophilized means freeze-dried. Your pharmacy will tell you how much bacteriostatic water to add.

Draw the specified volume of bacteriostatic water into a separate syringe.
Inject the water slowly into the vial — aim at the glass wall, not directly at the powder.
Swirl gently until the powder dissolves completely. Never shake — shaking damages the peptide structure.
The solution should be clear with no floating particles. Discard if it looks cloudy or has debris.
Write the date of reconstitution on the vial label.
Draw your dose using the liquid preparation steps above.

Learn more about reconstituting lyophilized peptides and stability windows by compound.

Step-by-step Injection Procedure

Read through all steps before your first injection.

Step 1 — Pick your site

Choose from: the lower abdomen (at least 2 inches from your navel in any direction) or the outer thigh (mid-thigh on the outside surface). Avoid any spot that’s bruised, scarred, lumpy, or that you injected in the last 7–10 days. See the rotation section below for a full schedule.

Step 2 — Clean the site

Wipe the chosen spot with a fresh alcohol pad in a circular motion from the center outward. Let it air-dry for 10–15 seconds. Do not blow on it or wave your hand over it. Injecting into a wet alcohol site stings more and increases contamination risk.

Step 3 — Pinch the skin

With your non-dominant hand, gently pinch about 1–2 inches of skin and fat between your thumb and forefinger. This lifts the fat layer away from the muscle underneath — which is the tissue layer you’re targeting.

Step 4 — Insert the needle

Hold the syringe like a dart in your dominant hand. Insert in one smooth, swift motion:

If you have normal body fat: insert at 90 degrees (straight in, perpendicular to skin)
If you are very lean with minimal fat: insert at 45 degrees (angled in)

Push the needle in about halfway — roughly half an inch. Swift insertion is less uncomfortable than slow insertion.

Step 5 — Inject slowly

Release the skin pinch. Push the plunger down slowly and steadily over about 3–5 seconds. Rapid injection causes stinging and uneven medication distribution.

Step 6 — Withdraw

Pull the needle straight out at the same angle it entered — smooth and swift. Do not twist or wiggle.

Step 7 — Dispose of the needle immediately

Do not recap the needle. Do not set it on the counter. Place the used syringe directly into your FDA-cleared sharps container. This step happens before anything else.

Step 8 — Care for the site

Apply gentle pressure with clean gauze if the site bleeds slightly — this is normal and stops within seconds. Do not rub. Wash your hands again.

Learn more about troubleshooting common injection technique issues.

Injection Sites and Rotation

Reusing the same injection spot causes tissue damage that blocks absorption.

Repeatedly injecting into the same location causes lipohypertrophy — abnormal fatty lumps that form when tissue is repeatedly irritated. Medication injected into these lumps absorbs unpredictably or not at all. Hardened tissue can make it difficult to feel the needle going in, which makes the problem easy to overlook.

Your two primary injection zones:

Lower abdomen: Imagine a clock face centered on your navel. Every injection goes outside the 2-inch radius from center — nothing inside that ring. Divide the usable area into four quadrants: upper-right, lower-right, lower-left, upper-left.

Outer thigh: The outer surface of your mid-thigh on both legs. Avoid the inner thigh, where major blood vessels run.

Daily rotation schedule:

Day	Zone
Day 1	Abdomen — upper right
Day 2	Abdomen — lower right
Day 3	Abdomen — lower left
Day 4	Abdomen — upper left
Day 5	Right thigh
Day 6	Left thigh
Day 7	Back to abdomen — upper right

Within each zone, move at least one inch from the previous injection spot. No site should be reused within 7–10 days. Healthy tissue absorbs medication consistently. Damaged tissue does not.

Learn more about managing injection site health for long-term peptide protocols.

Sharps Disposal and Safety

Required by federal law: Under OSHA’s Bloodborne Pathogens Standard (29 CFR 1910.1030), used needles must go into an FDA-cleared sharps disposal container immediately after use. This applies to home self-administration, not just clinical settings.

Key takeaways

Fill your sharps container only to the ¾ full line — overfilling causes needlestick injuries during disposal.
Never recap, bend, or break used needles.
Needlestick injuries from used needles can transmit HIV, Hepatitis B, and Hepatitis C (CDC).
If you accidentally stick yourself with a used needle, call the CDC’s PEP hotline: 1-888-448-4911 (available 24/7).

What an FDA-cleared sharps container must have:

Heavy-duty puncture-resistant plastic walls and bottom
A tight-fitting lid that will not come off
A clear biohazard warning label
Leak resistance

Standard sharps containers are available at any pharmacy, medical supply store, or online. Keep the container within arm’s reach while injecting so disposal is immediate.

Rules for use:

Never fill above the ¾ full line — overfilled containers cause needlestick injuries when the lid is applied. Never recap used needles, bend them, or break them. Never put loose needles in regular trash, recycling, or down the toilet.

Temporary measure only: If you do not yet have an FDA-cleared container, OSHA permits a heavy-duty household plastic bottle with a screw-on cap (such as an empty laundry detergent bottle) labeled “SHARPS — DO NOT RECYCLE.” This is a temporary measure — obtain a proper sharps container as soon as possible.

Why these rules exist:

The CDC documents that needlestick injuries from used needles can transmit HIV, Hepatitis B, and Hepatitis C. These are the reasons the Bloodborne Pathogens Standard exists.

How to dispose of a full sharps container:

Check your state’s rules at SafeNeedleDisposal.org. Most areas offer at least one of: sharps mail-back programs, pharmacy drop-off locations, or household hazardous waste collection events.

If you get a needlestick from a used needle:

Wash the area immediately and thoroughly with soap and water.
Seek medical evaluation the same day.
Call the CDC’s Post-Exposure Prophylaxis (PEP) hotline: 1-888-448-4911 (24 hours a day, 7 days a week).

Learn more about sharps disposal options in your state at SafeNeedleDisposal.org.

Storage and Handling

Peptides are fragile. Both heat and freezing damage their structure.

Peptide state	Storage temperature	Notes
Lyophilized (dry powder, before mixing)	Room temperature	Keep in original packaging, away from direct light
Reconstituted (mixed with water, in vial)	2–8°C (36–46°F) refrigerator	Store upright, in original packaging — never freeze

Rules that apply across all peptides:

Store away from direct light — keep in the original box or wrap the vial in foil. Never freeze reconstituted peptides; freezing denatures the protein structure and eliminates the therapeutic effect. Never store near heat sources such as windowsills, car gloveboxes, or kitchen appliances.

Check the expiration or beyond-use date before every injection. Inspect the solution before drawing your dose — it should be clear with no visible particles. Discard if it’s cloudy, discolored, or has anything floating in it, even if it’s within the dating window.

Reconstituted peptide stability:

Stability depends on the specific compound. Sermorelin is typically stable for 30 days refrigerated. NAD+ stability varies by formulation. Your pharmacy will provide a beyond-use date on the label — follow that date, not general guidelines. Write the reconstitution date directly on the vial label at the time of mixing.

Learn more about storage requirements and stability windows for specific peptide compounds.

Reactions: What to Watch For

Most reactions at the injection site are minor and temporary. A few require prompt attention.

Normal reactions — no action needed:

Reaction	Typical duration
Mild pain or tenderness at the site	Resolves within a few hours
Small area of redness or pinkness	Fades within 24 hours
Minor bruising	Resolves over a few days
Slight tingling	Temporary

Reactions that require calling your provider:

Injection site pain, swelling, or redness lasting more than 24 hours
Warmth spreading outward from the injection site
Any pus or discharge at the site
Red streaks extending from the site
Fever or chills following an injection

Reactions that require calling 911:

Signs of anaphylaxis — call 911 immediately. Do not wait to see if it passes.

Difficulty breathing or shortness of breath
Swelling of the face, lips, tongue, or throat
Hives breaking out across the body
Rapid or irregular heartbeat
Sudden dizziness or loss of consciousness

Anaphylaxis is a serious allergic reaction that can be life-threatening within minutes.

Learn more about recognizing and responding to injection site reactions.

Peptides and Legal Sourcing

Where your peptide comes from affects both its legality and your safety.

Key takeaways

FDA-approved injectables like liraglutide (Victoza, Saxenda) and semaglutide (Ozempic, Wegovy) are available through standard pharmacies with a valid prescription.
Sermorelin and NAD+ can be legally obtained through licensed 503A compounding pharmacies with a valid prescription.
BPC-157, CJC-1295, and ipamorelin are FDA Category 2 substances and cannot be legally compounded in the US under current regulations.
Independent testing has found purity levels as low as 60% in research-grade products versus 95% or above in pharmaceutical-grade compounds (Innerbody Research, 2026).

Current regulatory status by peptide:

Peptide	Regulatory status	Legal compounding status
Liraglutide (Victoza, Saxenda)	FDA-approved 2010	Available through standard pharmacies with Rx
Semaglutide (Ozempic, Wegovy)	FDA-approved	Available through standard pharmacies with Rx
Tirzepatide (Zepbound)	FDA-approved	Available through standard pharmacies with Rx
Sermorelin	FDA-approved 1991; commercial product withdrawn 2008 (business decision, not safety)	Available from licensed 503A compounding pharmacies with Rx
NAD+	FDA GRAS status; appears on 503A Bulks List	Legally compoundable with valid Rx
Glutathione	No FDA approval for injectable route	Available from licensed 503A pharmacies
BPC-157	FDA Category 2 (safety concerns raised)	Cannot be legally compounded; no licensed US source currently
CJC-1295, Ipamorelin	FDA Category 2	Cannot be legally compounded under current regulations

What makes a compounding pharmacy legitimate:

A licensed 503A pharmacy must hold a valid state board of pharmacy license, source all active pharmaceutical ingredients (APIs) from FDA-registered manufacturers, and provide a Certificate of Analysis (CoA) showing purity and potency for your specific medication. It must also follow USP Standard 797 for sterile preparations and USP Standard 795 for non-sterile preparations, and require a valid, patient-specific prescription before dispensing.

You can verify a pharmacy’s state license at your state board of pharmacy’s website. Ask your pharmacy for a CoA before filling any injectable prescription — a legitimate operation will provide one without hesitation.

Research-grade peptides sold online are not a legal alternative for human use. They are marketed for laboratory use only and are not subject to purity, sterility, or dosing accuracy standards. Independent testing has found purity levels as low as 60% in research-grade products versus 95% or above in pharmaceutical-grade compounds (Innerbody Research, 2026). Injecting an unverified substance bypasses every safety mechanism described in this guide.

Learn more about verifying a compounding pharmacy’s credentials and checking your peptide’s current FDA status at FDA.gov.

The Bottom Line

Subcutaneous peptide injection becomes routine with practice — the technique itself is not complicated. What separates safe self-administration from risky self-administration is consistency around the parts people tend to rush: hand washing, site rotation, and immediate sharps disposal. Source your peptides through a licensed prescriber and a licensed compounding pharmacy or FDA-approved manufacturer, and follow your physician’s specific dosing instructions exactly. If anything unusual happens after an injection — particularly difficulty breathing or facial swelling — call 911 first. Talk with a licensed physician to determine which peptide therapy, if any, is appropriate for your goals and medical history.

Frequently Asked Questions

How do I mix lyophilized (powdered) peptide for injection?

Draw the bacteriostatic water volume your pharmacy specifies into a syringe, inject it slowly into the vial by aiming at the glass wall rather than the powder, then swirl gently until the powder is fully dissolved — never shake. The solution should be completely clear. Mark the mixing date on the vial label, refrigerate at 2–8°C, and use within the stability window on your pharmacy label. For most reconstituted peptides this is approximately 30 days, though it varies by compound.

Can I use a different needle gauge for subcutaneous injections?

Yes, within a range. Gauges 27–31 work for subcutaneous injections. A 31-gauge needle is the thinnest and least uncomfortable. A 27-gauge needle flows faster but causes more discomfort and may increase bruising. For particularly viscous medications, a slightly thicker gauge may be necessary — your pharmacist can advise. Do not change the needle specification without checking with your provider first.

What if I’m not sure I drew the correct dose?

Do not inject. Push everything back into the vial through the needle, redraw carefully, and cross-check against your prescription label. If you remain uncertain after redrawing, call your pharmacy before injecting. Both underdosing and overdosing carry real risks with prescription medications — accuracy matters every time.

When should I call my doctor after an injection?

Call immediately for any of the following: difficulty breathing, face or throat swelling, hives, rapid heartbeat, infection signs (pus, red streaks from the site, fever), or severe site pain and swelling lasting more than 24 hours. Mild redness, minor bruising, and temporary tenderness are normal and resolve on their own. When in doubt, call — your provider would rather hear from you than have you wait through a developing complication.

How long does reconstituted peptide stay good in the refrigerator?

It depends on the specific compound. Sermorelin is typically stable for 30 days refrigerated at 2–8°C. NAD+ stability varies by formulation. Always follow the beyond-use date printed on your pharmacy label. Inspect the solution before every use — discard if it has become cloudy, changed color, or has visible particles, even if it’s within the dating window.

Is subcutaneous injection the same as intramuscular (IM) injection?

No. Subcutaneous targets the fat layer (about half an inch deep, 45–90 degree angle, 29–31 gauge needle). Intramuscular targets muscle tissue (about one inch deep, 90 degrees, 22–25 gauge needle). The tissue layers, needle sizes, absorption speeds, and appropriate medications are all different. Peptides are almost always subcutaneous. Never switch routes without your physician’s explicit instruction — delivering a medication to the wrong tissue layer changes how and how fast it absorbs.

What should I do if I accidentally stick myself with a used needle?

Wash the area immediately and thoroughly with soap and water, then seek medical evaluation the same day. Call the CDC’s Post-Exposure Prophylaxis (PEP) hotline at 1-888-448-4911, available 24 hours a day, 7 days a week. Post-exposure prophylaxis is time-sensitive — do not delay seeking care.

Considering peptide therapy? Speak with a licensed physician who can review your labs and discuss whether any injectable peptide protocol is appropriate for your situation.

References

OSHA Bloodborne Pathogens Standard. 29 CFR 1910.1030. United States Department of Labor, Occupational Safety and Health Administration. Governs sharps disposal requirements, container specifications, and disposal timing (¾ full rule).
CDC. Needlestick Safety and Prevention. Centers for Disease Control and Prevention. Documents HIV, Hepatitis B, and Hepatitis C transmission risk from sharps injuries; Post-Exposure Prophylaxis hotline 1-888-448-4911.
FDA. Liraglutide (Victoza, Saxenda) approval history. FDA.gov. First approval 2010 for type 2 diabetes; 2014 for obesity.
FDA. Bulk Drug Substances Used in Compounding Under Section 503A — current listings including NAD+. FDA.gov.
USP Standard 797 (Pharmaceutical Compounding — Sterile Preparations) and USP Standard 795 (Pharmaceutical Compounding — Nonsterile Preparations). United States Pharmacopeia.
SafeNeedleDisposal.org. State-by-state sharps disposal location finder. Operated by the Coalition for Safe Community Needle Disposal.
Federal Food, Drug, and Cosmetic Act (FDCA), Section 503A (21 U.S.C. 353a). Compounding pharmacy legal framework.
Innerbody Research. Beginner’s Guide to Peptide Therapy. Updated January 2026. (Research-grade purity levels as low as 60% cited in that source.)
Sermorelin “withdrawn 2008 for business reasons, not safety”: This claim appears consistently across multiple sources. A direct FDA correspondence or manufacturer announcement confirming this distinction would strengthen the citation before publication.
Peptide molecular weight threshold <16 kDa for capillary absorption: cited in the brief as an EAV attribute. A PubMed-indexed pharmacokinetics study confirming this threshold for subcutaneous peptide absorption should be provided by the medical reviewer before publication.
20-second hand washing: standard CDC hand hygiene guideline. Citation: CDC Hand Hygiene in Healthcare Settings guidelines — medical reviewer should confirm this is the appropriate source for a patient-facing guide.

Disclaimer: PeptideRx provides physician-reviewed educational content about peptide therapy. PeptideRx does not provide medical advice, diagnosis, or treatment. The peptides discussed in this guide are not FDA-approved for general human therapeutic use unless otherwise specified. All dosing and procedural information reflects published research protocols and established medical standards, not prescribing recommendations. Subcutaneous self-injection carries medical risks and must be performed under the guidance of a licensed healthcare provider. Never begin any injectable peptide protocol without a valid prescription and explicit instructions from your prescribing physician or pharmacist. All injectable peptides obtained for therapeutic use must come from licensed 503A or 503B compounding pharmacies or FDA-approved manufacturers. FDA Category 2 peptides (including BPC-157 and ipamorelin) cannot be legally compounded under current regulations. Verify current FDA bulk drug substance status at FDA.gov. OSHA sharps disposal standards apply regardless of setting.